Journal
EXPERIMENTAL BRAIN RESEARCH
Volume 236, Issue 4, Pages 955-961Publisher
SPRINGER
DOI: 10.1007/s00221-018-5191-9
Keywords
Putamen; Caudate; MPTP; Photobiomodulation; Acetylcholine; OPN3
Categories
Funding
- Michael J Fox Foundation
- Credit Agricole Sud Rhones Alpes
- Fondation Philanthropique Edmond J Safra
- France Parkinson
- French National Research Agency (ANR Carnot Institute)
- Tenix corp
- Salteri family
Ask authors/readers for more resources
In this study, we examined the cellular distribution of encephalopsin (opsin 3; OPN3) expression in the striatum of non-human primates. In addition, because of our long standing interest in Parkinson's disease and neuroprotection, we examined whether parkinsonian (MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) insult and/or photobiomodulation (670 nm) had any impact on encephalopsin expression in this key area of the basal ganglia. Striatal sections of control na < ve monkeys, together with those that were either MPTP- and/or photobiomodulation-treated were processed for immunohistochemistry. Our results revealed two populations of striatal interneurones that expressed encephalopsin, one of which was the giant, choline acetyltransferase-containing, cholinergic interneurones. The other population had smaller somata and was not cholinergic. Neither cell group expressed the calcium-binding protein, parvalbumin. There was also rich encephalopsin expression in a set of terminals forming striosome-like patches across the striatum. Finally, we found that neither parkinsonian (MPTP) insult nor photobiomodulation had any effect on encephalopsin expression in the striatum. In summary, our results revealed an extensive network of encephalopsin containing structures throughout the striatum, indicating that external light is in a position to influence a range of striatal activities at both the interneurone and striosome level.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available